"10.1371_journal.pone.0053621","plos one","2013-01-17T00:00:00Z","Charlotte Charpentier; Catherine Fagard; Céline Colin; Christine Katlama; Jean-Michel Molina; Christine Jacomet; Benoit Visseaux; Anne-Marie Taburet; Françoise Brun-Vézinet; Geneviève Chêne; Yazdan Yazdanpanah; Diane Descamps; the ANRS139 TRIO Trial study group","Laboratoire de Virologie, Assistance Publique-Hôpitaux de Paris (AP-HP), Groupe Hospitalier Bichat-Claude Bernard, HUPNVS, Université Paris Diderot, Paris 7, PRES Sorbonne Paris Cité, EA4409, Paris, France; Université de Bordeaux, ISPED, Centre INSERM U897-Epidémiologie Statistique, Bordeaux, France; INSERM, ISPED, Centre INSERM U897-Epidémiologie Statistique, Bordeaux, France; AP-HP, Hôpital Pitié-Salpêtrière, Service de Maladies Infectieuses, INSERM U943, UPMC, Paris 6, Paris, France; AP-HP, Hôpital Saint-Louis, Service de Maladies Infectieuses, Université Paris-Diderot, Paris 7, Paris, France; Hôpital Gabriel Montpied, Clermont-Ferrand, France; AP-HP, Hôpital Bicêtre, Hôpitaux Universitaires Paris Sud, Pharmacie service de pharmacie clinique, CHU de Bicêtre, AP-HP, Le Kremlin Bicêtre, France; CHU de Bordeaux, Pôle de Santé Publique, Service dinformation médicale, Bordeaux, France; AP-HP, Groupe Hospitalier Bichat-Claude Bernard, HUPNVS, Service de Maladies Infectieuses, Université Paris-Diderot, Paris 7, Paris, France","Performed plasma dosages of antiretroviral drugs: AMT. Performed statistical analysis: CF C. Colin GC. Performed the virological analysis: C. Charpentier BV. Recruited patients in the trial: CK JMM CJ. Conceived and designed the experiments: C. Charpentier CF YY DD. Analyzed the data: C. Charpentier CF FBV GC YY DD. Wrote the paper: C. Charpentier CF CK JMM CJ FBV GC YY DD.","The authors have the following interests. Merck Sharp & Dohme-Chibret provided raltegravir for this study which is marketed by them. Tibotec, a division of Janssen-Cilag, provided etravirine which is marketed by them. There are no further patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2013","01","Charlotte Charpentier","CC",13,TRUE,1,1,1,1,TRUE,TRUE,TRUE,5,"7;9;11;12;13",TRUE
